Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01073371
Other study ID # 131843/2008-7
Secondary ID
Status Completed
Phase Phase 1
First received February 19, 2010
Last updated February 22, 2010
Start date July 2008
Est. completion date November 2009

Study information

Verified date June 2008
Source University of Campinas, Brazil
Contact n/a
Is FDA regulated No
Health authority Brazil: National Committee of Ethics in Research
Study type Interventional

Clinical Trial Summary

This blinded randomized, crossover, three period study aim to evaluate the anesthetic efficacy of liposome-encapsulated 3% prilocaine compared to 3% plain prilocaine and 3% prilocaine with 0,03IU/mL felypressin, after 1.8mL infiltration in the buccal sulcus of the maxillary right canine, in 32 volunteers.


Recruitment information / eligibility

Status Completed
Enrollment 32
Est. completion date November 2009
Est. primary completion date August 2009
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria:

- good health

- no history of allergy to the components of the local anesthetic formulations tested

- maxillary canine, lateral incisor, and first premolar responsible to electric stimulation

Exclusion Criteria:

- intake of any medication that would alter pain perception

- history of trauma or sensitivity, caries, restorations, periodontal disease and endodontic treatment in the maxillary canine, lateral incisor, and first premolar

- systemic disease

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Drug:
Prilocaine
1.8mL infiltration of liposome-encapsulated 3% prilocaine, 3% plain prilocaine or 3% prilocaine with 0,03IU/mL felypressin in the buccal sulcus of the maxillary right canine

Locations

Country Name City State
Brazil Piracicaba Dental School Piracicaba SP

Sponsors (3)

Lead Sponsor Collaborator
University of Campinas, Brazil Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado de São Paulo

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Anesthesia success, onset and duration of pulpal and gingival anesthesia. 10 minutes No
Secondary Injection pain - Visual Analogue Scale 1 minute after the injections No
See also
  Status Clinical Trial Phase
Completed NCT01302483 - Safety and Effectiveness of Kovacaine Nasal Spray for Dental Anesthesia Phase 2